Chang-Baeg Lim

Title: Innovations of Chang-Baeg Lim in Drug Delivery Systems.

Introduction

Chang-Baeg Lim is a notable inventor based in Taejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly focusing on colon-selective delivery mechanisms. His innovative approach aims to enhance the effectiveness of drug administration by targeting specific areas within the gastrointestinal tract.

Latest Patents

Chang-Baeg Lim holds a patent for a "Colon selective drug delivery composition." This composition comprises gelatin and a polysaccharide that is degradable by colonic enzymes. Additionally, it may include an aldehyde, a polyvalent metal ion, and/or an additional polysaccharide that remains intact in the upper gastrointestinal tract. This innovative formulation allows for the selective delivery of active substances to the colon, ensuring effective release where it is most needed.

Career Highlights

Chang-Baeg Lim is associated with Samyang Corporation, where he continues to develop and refine his innovative drug delivery technologies. His work has garnered attention for its potential to improve therapeutic outcomes for patients requiring targeted drug administration.

Collaborations

He has collaborated with notable colleagues, including Seung-Seo Lee and Sung-Bum La, to advance research and development in the field of drug delivery systems.

Conclusion

Chang-Baeg Lim's contributions to colon-selective drug delivery compositions represent a significant advancement in pharmaceutical technology. His innovative work continues to pave the way for more effective treatment options in medicine.